28.12.2013 Views

LIVE POLIO IRUS VACCINES

LIVE POLIO IRUS VACCINES

LIVE POLIO IRUS VACCINES

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Discussion<br />

159<br />

Discussion 159<br />

ence in spread related to economic status, and its was not true of the Type 1 and Type 3 strains that<br />

related ecologic concomitants, such as crowding I selected.<br />

and family size.<br />

With Type 1, 1 found that even a dose of 10,000<br />

TCD 50 given to young adults produced infection<br />

DR. GEAR: One brief comment on this question. irregularly and when it occurred it was associated<br />

Similar change in incidence of poliomeylitis in with virus excretion for only about seven to 10<br />

the different economic groups has been noticed days; antibody could be demonstrated at four<br />

recently in communities in South Africa, in the weeks, but not at six or eight weeks.<br />

absence of Salk vaccination.<br />

This finding adds emphasis to the point raised<br />

by Dr. Paul, that is, that you cannot examine antibody<br />

just at one time after infection and have a<br />

complete picture.<br />

We also have evidence that some people can<br />

have infection for three to four weeks with Type<br />

3 virus and when the antibody is determined at<br />

a given point, six or eight weeks later, they have<br />

no demonstrable antibody by methods we now<br />

have available; however, when tested for resistance<br />

of the intestinal tract two years later, demonstrated<br />

a very marked resistance.<br />

Would Dr. Gelfand please answer the question<br />

I posed to him?<br />

DR. SABIN: I should like to comment on the<br />

subject of abortive infections, particularly in the<br />

light of the comments made by Dr. Dick and Dr.<br />

Smadel.<br />

In selecting the arbitrary titer of 32, which was<br />

necessitated by the circumstance of not knowing<br />

the status of natural immunity before Salk vaccine,<br />

we must realize that there were some<br />

naturally immune persons among those with the<br />

low titers, as well as some without naturally acquired<br />

immunity among those with the high<br />

titers; because some children do develop higher<br />

titers than 32 after three or four doses of Salk<br />

vaccine.<br />

Accordingly, some of the abortive infections<br />

could easily be accounted for on the basis of reinfection<br />

of previously naturally immune persons.<br />

Secondly, the failure of antibody response in<br />

some of these abortive infections might be accounted<br />

for on the basis of a high level of preexisting<br />

antibody. In our own studies of reinfection<br />

with Type 3 virus, we found that this particular<br />

type produced reinfection in 50 per cent of<br />

naturally immune adults and it may be higher in<br />

children. We found that if the pre-existing antibody<br />

titers were not very high, then even an abortive<br />

infection of one or two days' duration gave<br />

rise to an increase in antibody. But if the antibody<br />

levels were high to begin with, excretion of<br />

virus for a short period of time did not further<br />

boost the antibody level.<br />

I should like to ask Dr. Gelfand whether there<br />

were any children without any demonstrable antibody<br />

prior to oral vaccination, in whom an abortive<br />

infection occurred, and in whom there was<br />

no antibody response.<br />

1 should also like to comment on the remarks<br />

made by Dr. Dick. He worked with my Type 2<br />

virus strain, and my own titrations with this Type<br />

2 virus showed that it was capable of initiating<br />

infection with very small doses of virus, which<br />

DR. GELFAND: The answer to the first question<br />

is very simple. We did have individuals who had<br />

no antibody demonstrable by our technique, who<br />

experienced abortive infections of one, two, three,<br />

four, or five days, and who had no antibody when<br />

it was tested three months later.<br />

DR. SABIN: By the tube test?<br />

DR. GELFAND: Yes.<br />

DR. SABIN: I interposed this, because as our<br />

published data show, with this Type 3 strain we<br />

have had individuals who have had even longer<br />

periods of multiplication, three to four weeks,<br />

and yet by the tube neutralization test had no<br />

demonstrable antibody and by the pH test showed<br />

titers of 32 and 64.<br />

So this is another thing we must keep in mind<br />

in interpreting Dr. Gelfand's data.<br />

DR. GELFAND: I was reminded also that I had<br />

not answered Dr. Paul's earlier question about<br />

the proper time to do antibody studies following<br />

vaccination. 1 must say that the purpose of our<br />

study was not to acquire information about serologic<br />

response and we made no effort, as we probably<br />

should have, to collect a series of blood

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!